GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neutra Corp (OTCPK:NTRR) » Definitions » EBITDA Margin %

NTRR (Neutra) EBITDA Margin % : -43.75% (As of Apr. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Neutra EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Neutra's EBITDA for the three months ended in Apr. 2024 was $-0.01 Mil. Neutra's Revenue for the three months ended in Apr. 2024 was $0.03 Mil. Therefore, Neutra's EBITDA margin for the quarter that ended in Apr. 2024 was -43.75%.


Neutra EBITDA Margin % Historical Data

The historical data trend for Neutra's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neutra EBITDA Margin % Chart

Neutra Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5,916.67 -3,870.00 -538.04 -613.24 -452.50

Neutra Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -850.00 -1,475.00 -4,400.00 -96.43 -43.75

Competitive Comparison of Neutra's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Neutra's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neutra's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neutra's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Neutra's EBITDA Margin % falls into.



Neutra EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Neutra's EBITDA Margin % for the fiscal year that ended in Jan. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Jan. 2024 )/Revenue (A: Jan. 2024 )
=-0.181/0.04
=-452.50 %

Neutra's EBITDA Margin % for the quarter that ended in Apr. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Apr. 2024 )/Revenue (Q: Apr. 2024 )
=-0.014/0.032
=-43.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neutra  (OTCPK:NTRR) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Neutra EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Neutra's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neutra Business Description

Traded in Other Exchanges
N/A
Address
2500 CityWest Boulevard, Suite 150-161, Houston, TX, USA, 77042
Neutra Corp is a research and development company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. It sells hemp-derived products, including products containing delta-8-THC and other cannabinoids. Geographically, all the activities are operated through the region of the United States.
Executives
Sydney Jim director, officer: CEO & Chairman 8875 HIDDEN RIVER PARKWAY, SUITE 300, TAMPA FL 34243